Cat. No. Name Size Price Add Cart
KI0824Irsogladine maleate50 mg$154
Irsogladine maleate250 mg$368

Chemical Characteristic

Product NameIrsogladine maleate
SynonymsGaslon
CAS No.84504-69-8
Molecular Weight 372.16
FormulaC13H11Cl2N5O4
Chemical Structure

Biological activities

Irsogladine maleate is an anti-ulcer drug. Irsogladine maleate displays gastroprotective properties. Irsogladine maleate is an irsogladine salt of maleate. Irsogladine inhibits 7-ethoxyresorufin O-deethylation (CYP1A2) and tolbutamide hydroxylation (CYP2C9) with Ki of 276 and 156 µM, respectively.[1] Irsogladine also increases cAMP formation in a concentration-dependent manner in neutrophils. Irsogladine inhibits concentration-dependently the superoxide (O2-) production induced by various stimuli including formyl-methionyl-leucyl-phenylalanine, opsonized zymosan, guanosine 5閳?[gamma-thio] triphosphate, A23187 and phorbol 12-myristate 13-acetate. Irsogladine prevents the superoxide production in human neutrophils by the increase of cAMP content by PDE 4 inhibition.[2] Irsogladine protects gastric mucosa against various ulcerogenic stimuli through increasing cyclic AMP in surface mucous cells. Irsogladine dose-dependently facilitates gap-junctional intercellular communication (GJIC) in gastric epithelial cells. [3] Irsogladine administered orally significantly prevents in vivo angiogenesis in mice.[4] Irsogladine protects the small intestine against indomethacin-induced lesions.[5]

Protocols

In vivo: Irsogladine is suspended in a 0.5% hydroxy propyl cellulose solution.[5]

References

[1] Nakamura A, et al. Effects of irsogladine on P450-isoform specific activities in human hepatic microsomes. Arzneimittelforschung. 2006, 56(7): 547-552. 閵嗏偓閵嗏偓
[2] Kyoi T, et al. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci. 2004, 76(1): 71-83. 閵嗏偓閵嗏偓
[3] Ueda F, et al. Irsogladine activates gap-junctional intercellular communication through M1 muscarinic acetylcholine receptor. J Pharmacol Exp Ther. 1995, 274(2): 815-819. 閵嗏偓閵嗏偓
[4] Sato Y, et al. Irsogladine is a potent inhibitor of angiogenesis. FEBS Lett. 1993, 322(2): 155-158. 閵嗏偓閵嗏偓
[5] Kamei K, et al. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats. Dig Dis Sci. 2008, 53(10): 2657-2666. 閵嗏偓閵嗏偓

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.